by Barry101 | May 31, 2017 | Press Release
Joseph C. Horvath, M.D., Named Deputy Chief Medical Officer to Oversee Ampligen European Pancreatic Cancer Programs PHILADELPHIA, May 31, 2017 — Hemispherx Biopharma (NYSE MKT:HEB) (“Hemispherx” or the “Company”) announced today that it...
by Barry101 | May 31, 2017 | Press Release
Promotes Carol Smith, Ph.D., to Chief Manufacturing Officer and Deputy Chief Scientific OfficerPHILADELPHIA, May 31, 2017 — Hemispherx Biopharma (NYSE MKT:HEB) (“Hemispherx” or the “Company”) announced today that it continues to build its...
by Barry101 | May 15, 2017 | Press Release
The company has generated revenues from the lots of newly manufactured AmpligenPHILADELPHIA, May 15, 2017 — Hemispherx Biopharma (NYSE MKT:HEB) announced its financial results for the three months ended March 31, 2017. The net loss was approximately $2,821,000...
